Industry Research Reports

Home > Reports > Chemical & Material > Global Filgotinib Market Insights, Forecast to 2030

Global Filgotinib Market Insights, Forecast to 2030

Industry: Chemical & Material

Published Date: 2024-04-07

Pages: 105 Pages

Report ld: 2824834

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.

The global Filgotinib market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Filgotinib is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Filgotinib is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Filgotinib is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key manufacturers of Filgotinib include Cayman Chemical, BioVision, Adooq Bioscience, Taiclone, Clearsynth, Biorbyt, APExBIO Technology, Selleck Chemicals and AbMole, etc. In 2023, the global top five players had a share approximately % in terms of revenue.

In terms of production side, this report researches the Filgotinib production, growth rate, market share by manufacturers and by region (region level and country level), from 2019 to 2024, and forecast to 2030.

In terms of consumption side, this report focuses on the sales of Filgotinib by region (region level and country level), by company, by Type and by Application. from 2019 to 2024 and forecast to 2030.

Report Covers:

This report presents an overview of global market for Filgotinib, capacity, output, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2024, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Filgotinib, also provides the consumption of main regions and countries. Highlights of the upcoming market potential for Filgotinib, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Filgotinib sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Filgotinib market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Filgotinib sales, projected growth trends, production technology, application and end-user industry.

MARKET SEGMENTATION

By Company

Cayman Chemical
BioVision
Adooq Bioscience
Taiclone
Clearsynth
Biorbyt
APExBIO Technology
Selleck Chemicals
AbMole
BOC Sciences
TargetMol
Toronto Research Chemicals
J&K Scientific

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Min Purity Less Than 98%
Min Purity 98%-99%
Min Purity More Than 99%

Segment by Application

Research
Medical

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Filgotinib production/output of global and key producers (regions/countries). It provides a quantitative analysis of the production, and development potential of each producer in the next six years.

Chapter 3: Sales (consumption), revenue of Filgotinib in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Filgotinib manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, sales, and revenue for each segment.

Chapter 9: China by Type, and by Application, sales, and revenue for each segment.

Chapter 10: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.

Chapter 11: Middle East, Africa, Latin America by Type, by Application and by country, sales, and revenue for each segment.

Chapter 12: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Filgotinib sales, revenue, price, gross margin, and recent development, etc.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 15: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Study Coverage

1.1 Filgotinib Product Introduction

1.2 Market by Type

1.2.1 Global Filgotinib Market Size by Type, 2019 VS 2023 VS 2030

1.2.2 Min Purity Less Than 98%

1.2.3 Min Purity 98%-99%

1.2.4 Min Purity More Than 99%

1.3 Market by Application

1.3.1 Global Filgotinib Market Size by Application, 2019 VS 2023 VS 2030

1.3.2 Research

1.3.3 Medical

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Filgotinib Production

2.1 Global Filgotinib Production Capacity (2019-2030)

2.2 Global Filgotinib Production by Region: 2019 VS 2023 VS 2030

2.3 Global Filgotinib Production by Region

2.3.1 Global Filgotinib Historic Production by Region (2019-2024)

2.3.2 Global Filgotinib Forecasted Production by Region (2025-2030)

2.3.3 Global Filgotinib Production Market Share by Region (2019-2030)

2.4 North America

2.5 Europe

2.6 China

2.7 Japan

2.8 Taiwan,China

2.9 India

3 Executive Summary

3.1 Global Filgotinib Revenue Estimates and Forecasts 2019-2030

3.2 Global Filgotinib Revenue by Region

3.2.1 Global Filgotinib Revenue by Region: 2019 VS 2023 VS 2030

3.2.2 Global Filgotinib Revenue by Region (2019-2024)

3.2.3 Global Filgotinib Revenue by Region (2025-2030)

3.2.4 Global Filgotinib Revenue Market Share by Region (2019-2030)

3.3 Global Filgotinib Sales Estimates and Forecasts 2019-2030

3.4 Global Filgotinib Sales by Region

3.4.1 Global Filgotinib Sales by Region: 2019 VS 2023 VS 2030

3.4.2 Global Filgotinib Sales by Region (2019-2024)

3.4.3 Global Filgotinib Sales by Region (2025-2030)

3.4.4 Global Filgotinib Sales Market Share by Region (2019-2030)

3.5 US & Canada

3.6 Europe

3.7 China

3.8 Asia (excluding China)

3.9 Middle East, Africa and Latin America

4 Competition by Manufactures

4.1 Global Filgotinib Sales by Manufacturers

4.1.1 Global Filgotinib Sales by Manufacturers (2019-2024)

4.1.2 Global Filgotinib Sales Market Share by Manufacturers (2019-2024)

4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Filgotinib in 2023

4.2 Global Filgotinib Revenue by Manufacturers

4.2.1 Global Filgotinib Revenue by Manufacturers (2019-2024)

4.2.2 Global Filgotinib Revenue Market Share by Manufacturers (2019-2024)

4.2.3 Global Top 10 and Top 5 Companies by Filgotinib Revenue in 2023

4.3 Global Filgotinib Sales Price by Manufacturers

4.4 Global Key Players of Filgotinib, Industry Ranking, 2022 VS 2023 VS 2024

4.5 Analysis of Competitive Landscape

4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)

4.5.2 Global Filgotinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

4.6 Global Key Manufacturers of Filgotinib, Manufacturing Base Distribution and Headquarters

4.7 Global Key Manufacturers of Filgotinib, Product Offered and Application

4.8 Global Key Manufacturers of Filgotinib, Date of Enter into This Industry

4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

5.1 Global Filgotinib Sales by Type

5.1.1 Global Filgotinib Historical Sales by Type (2019-2024)

5.1.2 Global Filgotinib Forecasted Sales by Type (2025-2030)

5.1.3 Global Filgotinib Sales Market Share by Type (2019-2030)

5.2 Global Filgotinib Revenue by Type

5.2.1 Global Filgotinib Historical Revenue by Type (2019-2024)

5.2.2 Global Filgotinib Forecasted Revenue by Type (2025-2030)

5.2.3 Global Filgotinib Revenue Market Share by Type (2019-2030)

5.3 Global Filgotinib Price by Type

5.3.1 Global Filgotinib Price by Type (2019-2024)

5.3.2 Global Filgotinib Price Forecast by Type (2025-2030)

6 Market Size by Application

6.1 Global Filgotinib Sales by Application

6.1.1 Global Filgotinib Historical Sales by Application (2019-2024)

6.1.2 Global Filgotinib Forecasted Sales by Application (2025-2030)

6.1.3 Global Filgotinib Sales Market Share by Application (2019-2030)

6.2 Global Filgotinib Revenue by Application

6.2.1 Global Filgotinib Historical Revenue by Application (2019-2024)

6.2.2 Global Filgotinib Forecasted Revenue by Application (2025-2030)

6.2.3 Global Filgotinib Revenue Market Share by Application (2019-2030)

6.3 Global Filgotinib Price by Application

6.3.1 Global Filgotinib Price by Application (2019-2024)

6.3.2 Global Filgotinib Price Forecast by Application (2025-2030)

7 US & Canada

7.1 US & Canada Filgotinib Market Size by Type

7.1.1 US & Canada Filgotinib Sales by Type (2019-2030)

7.1.2 US & Canada Filgotinib Revenue by Type (2019-2030)

7.2 US & Canada Filgotinib Market Size by Application

7.2.1 US & Canada Filgotinib Sales by Application (2019-2030)

7.2.2 US & Canada Filgotinib Revenue by Application (2019-2030)

7.3 US & Canada Filgotinib Sales by Country

7.3.1 US & Canada Filgotinib Revenue by Country: 2019 VS 2023 VS 2030

7.3.2 US & Canada Filgotinib Sales by Country (2019-2030)

7.3.3 US & Canada Filgotinib Revenue by Country (2019-2030)

7.3.4 United States

7.3.5 Canada

8 Europe

8.1 Europe Filgotinib Market Size by Type

8.1.1 Europe Filgotinib Sales by Type (2019-2030)

8.1.2 Europe Filgotinib Revenue by Type (2019-2030)

8.2 Europe Filgotinib Market Size by Application

8.2.1 Europe Filgotinib Sales by Application (2019-2030)

8.2.2 Europe Filgotinib Revenue by Application (2019-2030)

8.3 Europe Filgotinib Sales by Country

8.3.1 Europe Filgotinib Revenue by Country: 2019 VS 2023 VS 2030

8.3.2 Europe Filgotinib Sales by Country (2019-2030)

8.3.3 Europe Filgotinib Revenue by Country (2019-2030)

8.3.4 Germany

8.3.5 France

8.3.6 U.K.

8.3.7 Italy

8.3.8 Russia

9 China

9.1 China Filgotinib Market Size by Type

9.1.1 China Filgotinib Sales by Type (2019-2030)

9.1.2 China Filgotinib Revenue by Type (2019-2030)

9.2 China Filgotinib Market Size by Application

9.2.1 China Filgotinib Sales by Application (2019-2030)

9.2.2 China Filgotinib Revenue by Application (2019-2030)

10 Asia (excluding China)

10.1 Asia Filgotinib Market Size by Type

10.1.1 Asia Filgotinib Sales by Type (2019-2030)

10.1.2 Asia Filgotinib Revenue by Type (2019-2030)

10.2 Asia Filgotinib Market Size by Application

10.2.1 Asia Filgotinib Sales by Application (2019-2030)

10.2.2 Asia Filgotinib Revenue by Application (2019-2030)

10.3 Asia Filgotinib Sales by Region

10.3.1 Asia Filgotinib Revenue by Region: 2019 VS 2023 VS 2030

10.3.2 Asia Filgotinib Revenue by Region (2019-2030)

10.3.3 Asia Filgotinib Sales by Region (2019-2030)

10.3.4 Japan

10.3.5 South Korea

10.3.6 China Taiwan

10.3.7 Southeast Asia

10.3.8 India

11 Middle East, Africa and Latin America

11.1 Middle East, Africa and Latin America Filgotinib Market Size by Type

11.1.1 Middle East, Africa and Latin America Filgotinib Sales by Type (2019-2030)

11.1.2 Middle East, Africa and Latin America Filgotinib Revenue by Type (2019-2030)

11.2 Middle East, Africa and Latin America Filgotinib Market Size by Application

11.2.1 Middle East, Africa and Latin America Filgotinib Sales by Application (2019-2030)

11.2.2 Middle East, Africa and Latin America Filgotinib Revenue by Application (2019-2030)

11.3 Middle East, Africa and Latin America Filgotinib Sales by Country

11.3.1 Middle East, Africa and Latin America Filgotinib Revenue by Country: 2019 VS 2023 VS 2030

11.3.2 Middle East, Africa and Latin America Filgotinib Revenue by Country (2019-2030)

11.3.3 Middle East, Africa and Latin America Filgotinib Sales by Country (2019-2030)

11.3.4 Brazil

11.3.5 Mexico

11.3.6 Turkey

11.3.7 Israel

11.3.8 GCC Countries

12 Corporate Profiles

12.1 Cayman Chemical

12.1.1 Cayman Chemical Company Information

12.1.2 Cayman Chemical Overview

12.1.3 Cayman Chemical Filgotinib Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.1.4 Cayman Chemical Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

12.1.5 Cayman Chemical Recent Developments

12.2 BioVision

12.2.1 BioVision Company Information

12.2.2 BioVision Overview

12.2.3 BioVision Filgotinib Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.2.4 BioVision Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

12.2.5 BioVision Recent Developments

12.3 Adooq Bioscience

12.3.1 Adooq Bioscience Company Information

12.3.2 Adooq Bioscience Overview

12.3.3 Adooq Bioscience Filgotinib Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.3.4 Adooq Bioscience Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

12.3.5 Adooq Bioscience Recent Developments

12.4 Taiclone

12.4.1 Taiclone Company Information

12.4.2 Taiclone Overview

12.4.3 Taiclone Filgotinib Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.4.4 Taiclone Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

12.4.5 Taiclone Recent Developments

12.5 Clearsynth

12.5.1 Clearsynth Company Information

12.5.2 Clearsynth Overview

12.5.3 Clearsynth Filgotinib Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.5.4 Clearsynth Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

12.5.5 Clearsynth Recent Developments

12.6 Biorbyt

12.6.1 Biorbyt Company Information

12.6.2 Biorbyt Overview

12.6.3 Biorbyt Filgotinib Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.6.4 Biorbyt Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

12.6.5 Biorbyt Recent Developments

12.7 APExBIO Technology

12.7.1 APExBIO Technology Company Information

12.7.2 APExBIO Technology Overview

12.7.3 APExBIO Technology Filgotinib Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.7.4 APExBIO Technology Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

12.7.5 APExBIO Technology Recent Developments

12.8 Selleck Chemicals

12.8.1 Selleck Chemicals Company Information

12.8.2 Selleck Chemicals Overview

12.8.3 Selleck Chemicals Filgotinib Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.8.4 Selleck Chemicals Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

12.8.5 Selleck Chemicals Recent Developments

12.9 AbMole

12.9.1 AbMole Company Information

12.9.2 AbMole Overview

12.9.3 AbMole Filgotinib Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.9.4 AbMole Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

12.9.5 AbMole Recent Developments

12.10 BOC Sciences

12.10.1 BOC Sciences Company Information

12.10.2 BOC Sciences Overview

12.10.3 BOC Sciences Filgotinib Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.10.4 BOC Sciences Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

12.10.5 BOC Sciences Recent Developments

12.11 TargetMol

12.11.1 TargetMol Company Information

12.11.2 TargetMol Overview

12.11.3 TargetMol Filgotinib Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.11.4 TargetMol Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

12.11.5 TargetMol Recent Developments

12.12 Toronto Research Chemicals

12.12.1 Toronto Research Chemicals Company Information

12.12.2 Toronto Research Chemicals Overview

12.12.3 Toronto Research Chemicals Filgotinib Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.12.4 Toronto Research Chemicals Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

12.12.5 Toronto Research Chemicals Recent Developments

12.13 J&K Scientific

12.13.1 J&K Scientific Company Information

12.13.2 J&K Scientific Overview

12.13.3 J&K Scientific Filgotinib Capacity, Sales, Price, Revenue and Gross Margin (2019-2024)

12.13.4 J&K Scientific Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

12.13.5 J&K Scientific Recent Developments

13 Industry Chain and Sales Channels Analysis

13.1 Filgotinib Industry Chain Analysis

13.2 Filgotinib Key Raw Materials

13.2.1 Key Raw Materials

13.2.2 Raw Materials Key Suppliers

13.3 Filgotinib Production Mode & Process

13.4 Filgotinib Sales and Marketing

13.4.1 Filgotinib Sales Channels

13.4.2 Filgotinib Distributors

13.5 Filgotinib Customers

14 Filgotinib Market Dynamics

14.1 Filgotinib Industry Trends

14.2 Filgotinib Market Drivers

14.3 Filgotinib Market Challenges

14.4 Filgotinib Market Restraints

15 Key Finding in The Global Filgotinib Study

16 Appendix

16.1 Research Methodology

16.1.1 Methodology/Research Approach

16.1.2 Data Source

16.2 Author Details

16.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Filgotinib Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Table 2. Major Manufacturers of Min Purity Less Than 98%

Table 3. Major Manufacturers of Min Purity 98%-99%

Table 4. Major Manufacturers of Min Purity More Than 99%

Table 5. Global Filgotinib Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Table 6. Global Filgotinib Production by Region: 2019 VS 2023 VS 2030 (Kg)

Table 7. Global Filgotinib Production by Region (2019-2024) & (Kg)

Table 8. Global Filgotinib Production by Region (2025-2030) & (Kg)

Table 9. Global Filgotinib Production Market Share by Region (2019-2024)

Table 10. Global Filgotinib Production Market Share by Region (2025-2030)

Table 11. Global Filgotinib Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 12. Global Filgotinib Revenue by Region (2019-2024) & (US$ Million)

Table 13. Global Filgotinib Revenue by Region (2025-2030) & (US$ Million)

Table 14. Global Filgotinib Revenue Market Share by Region (2019-2024)

Table 15. Global Filgotinib Revenue Market Share by Region (2025-2030)

Table 16. Global Filgotinib Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Filgotinib Sales by Region (2019-2024) & (Kg)

Table 18. Global Filgotinib Sales by Region (2025-2030) & (Kg)

Table 19. Global Filgotinib Sales Market Share by Region (2019-2024)

Table 20. Global Filgotinib Sales Market Share by Region (2025-2030)

Table 21. Global Filgotinib Sales by Manufacturers (2019-2024) & (Kg)

Table 22. Global Filgotinib Sales Share by Manufacturers (2019-2024)

Table 23. Global Filgotinib Revenue by Manufacturers (2019-2024) & (US$ Million)

Table 24. Global Filgotinib Revenue Share by Manufacturers (2019-2024)

Table 25. Filgotinib Price by Manufacturers 2019-2024 (K USD/Kg)

Table 26. Global Key Players of Filgotinib, Industry Ranking, 2022 VS 2023 VS 2024

Table 27. Global Filgotinib Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 28. Global Filgotinib by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Filgotinib as of 2023)

Table 29. Global Key Manufacturers of Filgotinib, Manufacturing Base Distribution and Headquarters

Table 30. Global Key Manufacturers of Filgotinib, Product Offered and Application

Table 31. Global Key Manufacturers of Filgotinib, Date of Enter into This Industry

Table 32. Mergers & Acquisitions, Expansion Plans

Table 33. Global Filgotinib Sales by Type (2019-2024) & (Kg)

Table 34. Global Filgotinib Sales by Type (2025-2030) & (Kg)

Table 35. Global Filgotinib Sales Share by Type (2019-2024)

Table 36. Global Filgotinib Sales Share by Type (2025-2030)

Table 37. Global Filgotinib Revenue by Type (2019-2024) & (US$ Million)

Table 38. Global Filgotinib Revenue by Type (2025-2030) & (US$ Million)

Table 39. Global Filgotinib Revenue Share by Type (2019-2024)

Table 40. Global Filgotinib Revenue Share by Type (2025-2030)

Table 41. Filgotinib Price by Type (2019-2024) & (K USD/Kg)

Table 42. Global Filgotinib Price Forecast by Type (2025-2030) & (K USD/Kg)

Table 43. Global Filgotinib Sales by Application (2019-2024) & (Kg)

Table 44. Global Filgotinib Sales by Application (2025-2030) & (Kg)

Table 45. Global Filgotinib Sales Share by Application (2019-2024)

Table 46. Global Filgotinib Sales Share by Application (2025-2030)

Table 47. Global Filgotinib Revenue by Application (2019-2024) & (US$ Million)

Table 48. Global Filgotinib Revenue by Application (2025-2030) & (US$ Million)

Table 49. Global Filgotinib Revenue Share by Application (2019-2024)

Table 50. Global Filgotinib Revenue Share by Application (2025-2030)

Table 51. Filgotinib Price by Application (2019-2024) & (K USD/Kg)

Table 52. Global Filgotinib Price Forecast by Application (2025-2030) & (K USD/Kg)

Table 53. US & Canada Filgotinib Sales by Type (2019-2024) & (Kg)

Table 54. US & Canada Filgotinib Sales by Type (2025-2030) & (Kg)

Table 55. US & Canada Filgotinib Revenue by Type (2019-2024) & (US$ Million)

Table 56. US & Canada Filgotinib Revenue by Type (2025-2030) & (US$ Million)

Table 57. US & Canada Filgotinib Sales by Application (2019-2024) & (Kg)

Table 58. US & Canada Filgotinib Sales by Application (2025-2030) & (Kg)

Table 59. US & Canada Filgotinib Revenue by Application (2019-2024) & (US$ Million)

Table 60. US & Canada Filgotinib Revenue by Application (2025-2030) & (US$ Million)

Table 61. US & Canada Filgotinib Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 62. US & Canada Filgotinib Revenue by Country (2019-2024) & (US$ Million)

Table 63. US & Canada Filgotinib Revenue by Country (2025-2030) & (US$ Million)

Table 64. US & Canada Filgotinib Sales by Country (2019-2024) & (Kg)

Table 65. US & Canada Filgotinib Sales by Country (2025-2030) & (Kg)

Table 66. Europe Filgotinib Sales by Type (2019-2024) & (Kg)

Table 67. Europe Filgotinib Sales by Type (2025-2030) & (Kg)

Table 68. Europe Filgotinib Revenue by Type (2019-2024) & (US$ Million)

Table 69. Europe Filgotinib Revenue by Type (2025-2030) & (US$ Million)

Table 70. Europe Filgotinib Sales by Application (2019-2024) & (Kg)

Table 71. Europe Filgotinib Sales by Application (2025-2030) & (Kg)

Table 72. Europe Filgotinib Revenue by Application (2019-2024) & (US$ Million)

Table 73. Europe Filgotinib Revenue by Application (2025-2030) & (US$ Million)

Table 74. Europe Filgotinib Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 75. Europe Filgotinib Revenue by Country (2019-2024) & (US$ Million)

Table 76. Europe Filgotinib Revenue by Country (2025-2030) & (US$ Million)

Table 77. Europe Filgotinib Sales by Country (2019-2024) & (Kg)

Table 78. Europe Filgotinib Sales by Country (2025-2030) & (Kg)

Table 79. China Filgotinib Sales by Type (2019-2024) & (Kg)

Table 80. China Filgotinib Sales by Type (2025-2030) & (Kg)

Table 81. China Filgotinib Revenue by Type (2019-2024) & (US$ Million)

Table 82. China Filgotinib Revenue by Type (2025-2030) & (US$ Million)

Table 83. China Filgotinib Sales by Application (2019-2024) & (Kg)

Table 84. China Filgotinib Sales by Application (2025-2030) & (Kg)

Table 85. China Filgotinib Revenue by Application (2019-2024) & (US$ Million)

Table 86. China Filgotinib Revenue by Application (2025-2030) & (US$ Million)

Table 87. Asia Filgotinib Sales by Type (2019-2024) & (Kg)

Table 88. Asia Filgotinib Sales by Type (2025-2030) & (Kg)

Table 89. Asia Filgotinib Revenue by Type (2019-2024) & (US$ Million)

Table 90. Asia Filgotinib Revenue by Type (2025-2030) & (US$ Million)

Table 91. Asia Filgotinib Sales by Application (2019-2024) & (Kg)

Table 92. Asia Filgotinib Sales by Application (2025-2030) & (Kg)

Table 93. Asia Filgotinib Revenue by Application (2019-2024) & (US$ Million)

Table 94. Asia Filgotinib Revenue by Application (2025-2030) & (US$ Million)

Table 95. Asia Filgotinib Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 96. Asia Filgotinib Revenue by Region (2019-2024) & (US$ Million)

Table 97. Asia Filgotinib Revenue by Region (2025-2030) & (US$ Million)

Table 98. Asia Filgotinib Sales by Region (2019-2024) & (Kg)

Table 99. Asia Filgotinib Sales by Region (2025-2030) & (Kg)

Table 100. Middle East, Africa and Latin America Filgotinib Sales by Type (2019-2024) & (Kg)

Table 101. Middle East, Africa and Latin America Filgotinib Sales by Type (2025-2030) & (Kg)

Table 102. Middle East, Africa and Latin America Filgotinib Revenue by Type (2019-2024) & (US$ Million)

Table 103. Middle East, Africa and Latin America Filgotinib Revenue by Type (2025-2030) & (US$ Million)

Table 104. Middle East, Africa and Latin America Filgotinib Sales by Application (2019-2024) & (Kg)

Table 105. Middle East, Africa and Latin America Filgotinib Sales by Application (2025-2030) & (Kg)

Table 106. Middle East, Africa and Latin America Filgotinib Revenue by Application (2019-2024) & (US$ Million)

Table 107. Middle East, Africa and Latin America Filgotinib Revenue by Application (2025-2030) & (US$ Million)

Table 108. Middle East, Africa and Latin America Filgotinib Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)

Table 109. Middle East, Africa and Latin America Filgotinib Revenue by Country (2019-2024) & (US$ Million)

Table 110. Middle East, Africa and Latin America Filgotinib Revenue by Country (2025-2030) & (US$ Million)

Table 111. Middle East, Africa and Latin America Filgotinib Sales by Country (2019-2024) & (Kg)

Table 112. Middle East, Africa and Latin America Filgotinib Sales by Country (2025-2030) & (Kg)

Table 113. Cayman Chemical Company Information

Table 114. Cayman Chemical Description and Major Businesses

Table 115. Cayman Chemical Filgotinib Capacity Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 116. Cayman Chemical Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

Table 117. Cayman Chemical Recent Development

Table 118. BioVision Company Information

Table 119. BioVision Description and Major Businesses

Table 120. BioVision Filgotinib Capacity Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 121. BioVision Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

Table 122. BioVision Recent Development

Table 123. Adooq Bioscience Company Information

Table 124. Adooq Bioscience Description and Major Businesses

Table 125. Adooq Bioscience Filgotinib Capacity Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 126. Adooq Bioscience Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

Table 127. Adooq Bioscience Recent Development

Table 128. Taiclone Company Information

Table 129. Taiclone Description and Major Businesses

Table 130. Taiclone Filgotinib Capacity Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 131. Taiclone Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

Table 132. Taiclone Recent Development

Table 133. Clearsynth Company Information

Table 134. Clearsynth Description and Major Businesses

Table 135. Clearsynth Filgotinib Capacity Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 136. Clearsynth Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

Table 137. Clearsynth Recent Development

Table 138. Biorbyt Company Information

Table 139. Biorbyt Description and Major Businesses

Table 140. Biorbyt Filgotinib Capacity Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 141. Biorbyt Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

Table 142. Biorbyt Recent Development

Table 143. APExBIO Technology Company Information

Table 144. APExBIO Technology Description and Major Businesses

Table 145. APExBIO Technology Filgotinib Capacity Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 146. APExBIO Technology Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

Table 147. APExBIO Technology Recent Development

Table 148. Selleck Chemicals Company Information

Table 149. Selleck Chemicals Description and Major Businesses

Table 150. Selleck Chemicals Filgotinib Capacity Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 151. Selleck Chemicals Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

Table 152. Selleck Chemicals Recent Development

Table 153. AbMole Company Information

Table 154. AbMole Description and Major Businesses

Table 155. AbMole Filgotinib Capacity Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 156. AbMole Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

Table 157. AbMole Recent Development

Table 158. BOC Sciences Company Information

Table 159. BOC Sciences Description and Major Businesses

Table 160. BOC Sciences Filgotinib Capacity Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 161. BOC Sciences Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

Table 162. BOC Sciences Recent Development

Table 163. TargetMol Company Information

Table 164. TargetMol Description and Major Businesses

Table 165. TargetMol Filgotinib Capacity Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 166. TargetMol Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

Table 167. TargetMol Recent Development

Table 168. Toronto Research Chemicals Company Information

Table 169. Toronto Research Chemicals Description and Major Businesses

Table 170. Toronto Research Chemicals Filgotinib Capacity Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 171. Toronto Research Chemicals Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

Table 172. Toronto Research Chemicals Recent Development

Table 173. J&K Scientific Company Information

Table 174. J&K Scientific Description and Major Businesses

Table 175. J&K Scientific Filgotinib Capacity Sales (Kg), Revenue (US$ Million), Price (K USD/Kg) and Gross Margin (2019-2024)

Table 176. J&K Scientific Filgotinib Product Model Numbers, Pictures, Descriptions and Specifications

Table 177. J&K Scientific Recent Development

Table 178. Key Raw Materials Lists

Table 179. Raw Materials Key Suppliers Lists

Table 180. Filgotinib Distributors List

Table 181. Filgotinib Customers List

Table 182. Filgotinib Market Trends

Table 183. Filgotinib Market Drivers

Table 184. Filgotinib Market Challenges

Table 185. Filgotinib Market Restraints

Table 186. Research Programs/Design for This Report

Table 187. Key Data Information from Secondary Sources

Table 188. Key Data Information from Primary Sources

List of Figures

Figure 1. Filgotinib Product Picture

Figure 2. Global Filgotinib Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Filgotinib Market Share by Type in 2023 & 2030

Figure 4. Min Purity Less Than 98% Product Picture

Figure 5. Min Purity 98%-99% Product Picture

Figure 6. Min Purity More Than 99% Product Picture

Figure 7. Global Filgotinib Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)

Figure 8. Global Filgotinib Market Share by Application in 2023 & 2030

Figure 9. Research

Figure 10. Medical

Figure 11. Filgotinib Report Years Considered

Figure 12. Global Filgotinib Capacity, Production and Utilization (2019-2030) & (Kg)

Figure 13. Global Filgotinib Production Market Share by Region in Percentage: 2023 Versus 2030

Figure 14. Global Filgotinib Production Market Share by Region (2019-2030)

Figure 15. Filgotinib Production Growth Rate in North America (2019-2030) & (Kg)

Figure 16. Filgotinib Production Growth Rate in Europe (2019-2030) & (Kg)

Figure 17. Filgotinib Production Growth Rate in China (2019-2030) & (Kg)

Figure 18. Filgotinib Production Growth Rate in Japan (2019-2030) & (Kg)

Figure 19. Filgotinib Production Growth Rate in Taiwan,China (2019-2030) & (Kg)

Figure 20. Filgotinib Production Growth Rate in India (2019-2030) & (Kg)

Figure 21. Global Filgotinib Revenue, (US$ Million), 2019 VS 2023 VS 2030

Figure 22. Global Filgotinib Revenue 2019-2030 (US$ Million)

Figure 23. Global Filgotinib Revenue (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)

Figure 24. Global Filgotinib Revenue Market Share by Region in Percentage: 2023 Versus 2030

Figure 25. Global Filgotinib Revenue Market Share by Region (2019-2030)

Figure 26. Global Filgotinib Sales 2019-2030 ((Kg)

Figure 27. Global Filgotinib Sales (CAGR) by Region: 2019 VS 2023 VS 2030 (Kg)

Figure 28. Global Filgotinib Sales Market Share by Region (2019-2030)

Figure 29. US & Canada Filgotinib Sales YoY (2019-2030) & (Kg)

Figure 30. US & Canada Filgotinib Revenue YoY (2019-2030) & (US$ Million)

Figure 31. Europe Filgotinib Sales YoY (2019-2030) & (Kg)

Figure 32. Europe Filgotinib Revenue YoY (2019-2030) & (US$ Million)

Figure 33. China Filgotinib Sales YoY (2019-2030) & (Kg)

Figure 34. China Filgotinib Revenue YoY (2019-2030) & (US$ Million)

Figure 35. Asia (excluding China) Filgotinib Sales YoY (2019-2030) & (Kg)

Figure 36. Asia (excluding China) Filgotinib Revenue YoY (2019-2030) & (US$ Million)

Figure 37. Middle East, Africa and Latin America Filgotinib Sales YoY (2019-2030) & (Kg)

Figure 38. Middle East, Africa and Latin America Filgotinib Revenue YoY (2019-2030) & (US$ Million)

Figure 39. The Filgotinib Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023

Figure 40. The Top 5 and 10 Largest Manufacturers of Filgotinib in the World: Market Share by Filgotinib Revenue in 2023

Figure 41. Global Filgotinib Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 42. Global Filgotinib Sales Market Share by Type (2019-2030)

Figure 43. Global Filgotinib Revenue Market Share by Type (2019-2030)

Figure 44. Global Filgotinib Sales Market Share by Application (2019-2030)

Figure 45. Global Filgotinib Revenue Market Share by Application (2019-2030)

Figure 46. US & Canada Filgotinib Sales Market Share by Type (2019-2030)

Figure 47. US & Canada Filgotinib Revenue Market Share by Type (2019-2030)

Figure 48. US & Canada Filgotinib Sales Market Share by Application (2019-2030)

Figure 49. US & Canada Filgotinib Revenue Market Share by Application (2019-2030)

Figure 50. US & Canada Filgotinib Revenue Share by Country (2019-2030)

Figure 51. US & Canada Filgotinib Sales Share by Country (2019-2030)

Figure 52. U.S. Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 53. Canada Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 54. Europe Filgotinib Sales Market Share by Type (2019-2030)

Figure 55. Europe Filgotinib Revenue Market Share by Type (2019-2030)

Figure 56. Europe Filgotinib Sales Market Share by Application (2019-2030)

Figure 57. Europe Filgotinib Revenue Market Share by Application (2019-2030)

Figure 58. Europe Filgotinib Revenue Share by Country (2019-2030)

Figure 59. Europe Filgotinib Sales Share by Country (2019-2030)

Figure 60. Germany Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 61. France Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 62. U.K. Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 63. Italy Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 64. Russia Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 65. China Filgotinib Sales Market Share by Type (2019-2030)

Figure 66. China Filgotinib Revenue Market Share by Type (2019-2030)

Figure 67. China Filgotinib Sales Market Share by Application (2019-2030)

Figure 68. China Filgotinib Revenue Market Share by Application (2019-2030)

Figure 69. Asia Filgotinib Sales Market Share by Type (2019-2030)

Figure 70. Asia Filgotinib Revenue Market Share by Type (2019-2030)

Figure 71. Asia Filgotinib Sales Market Share by Application (2019-2030)

Figure 72. Asia Filgotinib Revenue Market Share by Application (2019-2030)

Figure 73. Asia Filgotinib Revenue Share by Region (2019-2030)

Figure 74. Asia Filgotinib Sales Share by Region (2019-2030)

Figure 75. Japan Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 76. South Korea Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 77. China Taiwan Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 78. Southeast Asia Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 79. India Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 80. Middle East, Africa and Latin America Filgotinib Sales Market Share by Type (2019-2030)

Figure 81. Middle East, Africa and Latin America Filgotinib Revenue Market Share by Type (2019-2030)

Figure 82. Middle East, Africa and Latin America Filgotinib Sales Market Share by Application (2019-2030)

Figure 83. Middle East, Africa and Latin America Filgotinib Revenue Market Share by Application (2019-2030)

Figure 84. Middle East, Africa and Latin America Filgotinib Revenue Share by Country (2019-2030)

Figure 85. Middle East, Africa and Latin America Filgotinib Sales Share by Country (2019-2030)

Figure 86. Brazil Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 87. Mexico Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 88. Turkey Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 89. Israel Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 90. GCC Countries Filgotinib Revenue (2019-2030) & (US$ Million)

Figure 91. Filgotinib Value Chain

Figure 92. Filgotinib Production Process

Figure 93. Channels of Distribution

Figure 94. Distributors Profiles

Figure 95. Bottom-up and Top-down Approaches for This Report

Figure 96. Data Triangulation

Figure 97. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Filgotinib market? zhanKai

The top companies in the global Filgotinib market are Cayman Chemical、BioVision、Adooq Bioscience.

Related Reports

Filgotinib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Filgotinib was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 141
USD 3950.00
(Single User License)
Global Filgotinib Market Research Report 2026
The global Filgotinib market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 144
USD 2900.00
(Single User License)
Global Filgotinib Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Filgotinib market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 156
USD 4900.00
(Single User License)
Filgotinib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Filgotinib was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 118
USD 3950.00
(Single User License)
Global Filgotinib Market Research Report 2025
The global market for Filgotinib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 100
USD 2900.00
(Single User License)
Global Filgotinib Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Filgotinib market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 93
USD 4250.00
(Single User License)
Filgotinib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Published Date: 2024-02-19
Pages: 126
USD 3950.00
(Single User License)
Global Filgotinib Market Research Report 2024
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Published Date: 2024-01-12
Pages: 97
USD 2900.00
(Single User License)

Filgotinib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Filgotinib was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 141
USD 3950.00 (Single User License)
Global Filgotinib Market Research Report 2026
The global Filgotinib market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 144
USD 2900.00 (Single User License)
Global Filgotinib Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Filgotinib market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 156
USD 4900.00 (Single User License)
Filgotinib- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Filgotinib was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 118
USD 3950.00 (Single User License)
Global Filgotinib Market Research Report 2025
The global market for Filgotinib was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 100
USD 2900.00 (Single User License)
Global Filgotinib Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Filgotinib market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 93
USD 4250.00 (Single User License)
Filgotinib - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Published: 2024-02-19
Pages: 126
USD 3950.00 (Single User License)
Global Filgotinib Market Research Report 2024
Filgotinib is a selective JAK1 inhibitor with IC50 of 10 nM, 28 nM, 810 nM, and 116 nM for JAK1, JAK2, JAK3, and TYK2, respectively.
Published: 2024-01-12
Pages: 97
USD 2900.00 (Single User License)